Kuniaki Takahashi1, MD; Daniel J.F.M. Thuijs2, MD, PhD; Hironori Hara1, MD; Rutao Wang3,4, MD; Friedrich-Wilhelm Mohr5, MD, PhD; Marie-Claude Morice6, MD, PhD; David R. Holmes Jr7, MD; Arie Pieter Kappetein2, MD, PhD; Stuart J. Head2, MD, PhD; Yoshinobu Onuma3, MD, PhD; Patrick W. Serruys3, MD, PhD
1. Department of Cardiology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands; 2. Department of Cardiothoracic Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands; 3. Department of Cardiology, National University of Ireland Galway (NUIG), Galway, Ireland; 4. Department of Cardiology, Radboud University, Nijmegen, the Netherlands; 5. University Department of Cardiac Surgery, Heart Centre Leipzig, Leipzig, Germany; 6. Department of Cardiology, Hôpital Privé Jacques Cartier, Ramsay Générale de Santé, Massy, France; 7. Department of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN, USA
The anatomical SYNTAX score (SS) has been considered an important tool in the quantitative assessment of the complexity of coronary artery disease (CAD) and in facilitating the risk stratification of patients undergoing revascularisation. However, the anatomical SS, obtained prior to revascularisation, has been shown not to be associated with short- and long-term clinical outcomes in patients who received coronary artery bypass grafting (CABG). These findings prompted the development of the CABG SS, assessing native residual stenotic lesions, taking into account the extent of revascularisation by bypass grafting, with the aim of helping to identify patients at higher risk ...